Antifungal Agents
... similar to Itraconazole - It was approved to prevent Candida and Aspergillus infections in severely immunocompromised patients and for the treatment of oropharyngeal candidiasis - Due to its spectrum of activity, posaconazole could possibly be used in the treatment of fungal infections caused by Muc ...
... similar to Itraconazole - It was approved to prevent Candida and Aspergillus infections in severely immunocompromised patients and for the treatment of oropharyngeal candidiasis - Due to its spectrum of activity, posaconazole could possibly be used in the treatment of fungal infections caused by Muc ...
drugs acting on the respiratory system bronchial asthma
... preferable for the relief of acute attack of bronchial asthma. - Administered by inhalation or subcutaneously. Side effects include arrhythmia and worsening of angina pectoris, increase blood pressure, tremors etc. Contraindication: - hypertension, arrhythmia, 2- Ephedrine: compared to epinephrine, ...
... preferable for the relief of acute attack of bronchial asthma. - Administered by inhalation or subcutaneously. Side effects include arrhythmia and worsening of angina pectoris, increase blood pressure, tremors etc. Contraindication: - hypertension, arrhythmia, 2- Ephedrine: compared to epinephrine, ...
Winter Feeding
... for drug residues in food animals. These tolerances are based on approved labeled uses for the drug. This is because the FDA only has data for drug residue depletion on the approved production class. The main production classes are beef, dairy, and veal. Many products have been approved for beef and ...
... for drug residues in food animals. These tolerances are based on approved labeled uses for the drug. This is because the FDA only has data for drug residue depletion on the approved production class. The main production classes are beef, dairy, and veal. Many products have been approved for beef and ...
Differential Cell Permeability and the Basis for
... The relationship of cell permeability phenomena to the selective activity of methotrexate (MTX) during therapy of the L1210 leukemia was examined. Drug uptake and loss in normal tissue (small intestine) and L1210 cells in the peritoneal cavity were measured following the administra tion of single s. ...
... The relationship of cell permeability phenomena to the selective activity of methotrexate (MTX) during therapy of the L1210 leukemia was examined. Drug uptake and loss in normal tissue (small intestine) and L1210 cells in the peritoneal cavity were measured following the administra tion of single s. ...
A Mechanistic Approach to Understanding the Factors Affecting
... Solubility is calculated on the basis of the largest strength manufactured. It is defined as the minimum solubility of drug across a pH range of 1 to 8 and at a temperature of 37 ± 0.5°C. High-solubility drugs are those with a ratio of dose to solubility volume that is less than or equal to 250 ml. ...
... Solubility is calculated on the basis of the largest strength manufactured. It is defined as the minimum solubility of drug across a pH range of 1 to 8 and at a temperature of 37 ± 0.5°C. High-solubility drugs are those with a ratio of dose to solubility volume that is less than or equal to 250 ml. ...
ISMP Medication Safety Alert
... Two fatalities occurred due to IV admixture errors that were not detected during the checking process. Checks performed after manual IV admixture preparation often involve the “syringe pullback” method, which is less than ideal. This type of error-prone check is based on the preparer’s memory of how ...
... Two fatalities occurred due to IV admixture errors that were not detected during the checking process. Checks performed after manual IV admixture preparation often involve the “syringe pullback” method, which is less than ideal. This type of error-prone check is based on the preparer’s memory of how ...
Ecstasy - a quick guide to drugs and alcohol
... when pregnant increases the risk of miscarriage. The use of amphetamine like substances such as ecstasy during Ecstasy tablet Image: U.S. Drug Enforcement Administration ...
... when pregnant increases the risk of miscarriage. The use of amphetamine like substances such as ecstasy during Ecstasy tablet Image: U.S. Drug Enforcement Administration ...
Contamination of Herbal Medicines
... found adulterated with PDE-5 inhibitors. Stamina-Rx contained pharmacological amounts of tadalafil (19.8 mg/tablet), and Super-X contained sildenafil (30.2 mg/capsule). Adulteration with vardenafil was not identified. Although herbal products are marketed as devoid of adverse ...
... found adulterated with PDE-5 inhibitors. Stamina-Rx contained pharmacological amounts of tadalafil (19.8 mg/tablet), and Super-X contained sildenafil (30.2 mg/capsule). Adulteration with vardenafil was not identified. Although herbal products are marketed as devoid of adverse ...
A millennial overview of transition metal chemistry
... are bound to metal atoms and how the entire electronic structure of the complex gives rise to the magnetic, spectroscopic and chemical properties of the complex. This is not to say that we do not still have challenging problems, but high quality calculations can now be done on compounds of whatever ...
... are bound to metal atoms and how the entire electronic structure of the complex gives rise to the magnetic, spectroscopic and chemical properties of the complex. This is not to say that we do not still have challenging problems, but high quality calculations can now be done on compounds of whatever ...
PHARMACOKINETIC/PHARMACODYNAMIC (PK/PD) MODELING: AN INVESTIGATIONAL TOOL FOR DRUG DEVELOPMENT Review Article
... relationship between dose, systemic drug concentrations, and time) to that of PD model (describing the relationship between systemic drug concentration and the effect vs time profile) and a statistical model (particularly, the intra- and inter-individual variability of PK and/or PD origin). PK/PD ap ...
... relationship between dose, systemic drug concentrations, and time) to that of PD model (describing the relationship between systemic drug concentration and the effect vs time profile) and a statistical model (particularly, the intra- and inter-individual variability of PK and/or PD origin). PK/PD ap ...
FORMULATION AND EVALUATION OF OLMESARTAN MEDOXOMIL FLOATING TABLETS
... antagonist use in the treatment of mild –moderate hypertension. This drug is weakly basic, lipophilic and having very less oral bioavailability of about 26%. Olmesartan Medoxomil inhibits type I angiotensin II receptor in the rennin angiotensin system, there by producing best antihypertensive action ...
... antagonist use in the treatment of mild –moderate hypertension. This drug is weakly basic, lipophilic and having very less oral bioavailability of about 26%. Olmesartan Medoxomil inhibits type I angiotensin II receptor in the rennin angiotensin system, there by producing best antihypertensive action ...
Adverse effects - Nursing Pharmacology
... • Primary use: treatment of fever and to relieve pain • Adverse effects: uncommon with therapeutic doses ...
... • Primary use: treatment of fever and to relieve pain • Adverse effects: uncommon with therapeutic doses ...
Drugs, Dose Forms, and Delivery Systems
... synthetic drugs. A naturally occurring drug like a barbiturate does not exist. Semisynthetic drugs contain both natural and synthetic molecules. An example would be semisynthetic penicillins, which combine artificially created molecules with naturally occurring ones. These new penicillin derivatives ...
... synthetic drugs. A naturally occurring drug like a barbiturate does not exist. Semisynthetic drugs contain both natural and synthetic molecules. An example would be semisynthetic penicillins, which combine artificially created molecules with naturally occurring ones. These new penicillin derivatives ...
Cardiovascular Safety Outcome Trials: A meeting report from the
... Considered an important methodology in evidence-based medicine, meta-analysis is a potentially useful technique in identifying CV safety issues, particularly within a particular drug development program where the drug of interest will be tested at several doses and in a variety of populations, contr ...
... Considered an important methodology in evidence-based medicine, meta-analysis is a potentially useful technique in identifying CV safety issues, particularly within a particular drug development program where the drug of interest will be tested at several doses and in a variety of populations, contr ...
The AL-1 Story
... rejected Genzyme's leukemia drug during a morning session for similar reasons. ...
... rejected Genzyme's leukemia drug during a morning session for similar reasons. ...
HIV Drug Resistance: What We Know and How We Know It
... • Assess extent of transmitted drug resistance (TDR). • Monitor the expected efficacy of first-line therapies. ...
... • Assess extent of transmitted drug resistance (TDR). • Monitor the expected efficacy of first-line therapies. ...
Eschenbacher High Alert Medication Presentation October 2007
... Any incident in which the use of a medication (drug or biologic) at any dose, may have resulted in an adverse outcome in a patient (JCAHO 2001) ...
... Any incident in which the use of a medication (drug or biologic) at any dose, may have resulted in an adverse outcome in a patient (JCAHO 2001) ...
Pharm-D_Curriculm
... lipids, Simple, Complex and Derived lipids), Reactions of Fatty acids and other Lipids, Essential fatty acids, Biological and pharmaceutical importance of lipids. c) Proteins and Amino acids: Chemistry, Classification of proteins and amino acids, Reactions of proteins and amino acids, Organizational ...
... lipids, Simple, Complex and Derived lipids), Reactions of Fatty acids and other Lipids, Essential fatty acids, Biological and pharmaceutical importance of lipids. c) Proteins and Amino acids: Chemistry, Classification of proteins and amino acids, Reactions of proteins and amino acids, Organizational ...
Maximum Strength Mucinex Fast-Max Severe Cold/Night Time Cold
... rash, nausea, or vomiting, consult a doctor promptly. Do not use ■ with any other drug containing acetaminophen (prescription or nonprescription). If you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist. ■ with any other drug containing diphenhydramine, even one used on ...
... rash, nausea, or vomiting, consult a doctor promptly. Do not use ■ with any other drug containing acetaminophen (prescription or nonprescription). If you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist. ■ with any other drug containing diphenhydramine, even one used on ...
Cocaine - drug info @ your library
... Several toxic reactions can follow the use of cocaine. Cocaine toxicity is often called cocaine overdose, but it can occur with relatively small doses, especially in combination with other drugs or when there are pre-existing medical conditions. Symptoms of cocaine toxicity may include: » nausea and ...
... Several toxic reactions can follow the use of cocaine. Cocaine toxicity is often called cocaine overdose, but it can occur with relatively small doses, especially in combination with other drugs or when there are pre-existing medical conditions. Symptoms of cocaine toxicity may include: » nausea and ...
Pharmacodynamics
... ratio” – Calc add’n agonist w/ varied concent’s antagonist – Ratio by which agonist must be incr’d to overcome competition by antagonist – Dependent on [antagonist]/KB – Can be used to calculate KB ...
... ratio” – Calc add’n agonist w/ varied concent’s antagonist – Ratio by which agonist must be incr’d to overcome competition by antagonist – Dependent on [antagonist]/KB – Can be used to calculate KB ...
Routes and Formulations
... insulin delivery. • Disadvantages – Should not be used for prolonged periods. – Drug often swallowed because often difficult to administer ...
... insulin delivery. • Disadvantages – Should not be used for prolonged periods. – Drug often swallowed because often difficult to administer ...
Drug acting on autonomic and central nervous systems
... fibers and voluntary muscles) is also cholinergic. 7. The answer is d. Acetylcholine will stimulates both muscarinic and nicotinic receptors. Atropine and scopolamine are competitive antagonists of acetylcholine at M-cholinergic receptors. Skeletal muscle contraction is mediated through Nm receptors ...
... fibers and voluntary muscles) is also cholinergic. 7. The answer is d. Acetylcholine will stimulates both muscarinic and nicotinic receptors. Atropine and scopolamine are competitive antagonists of acetylcholine at M-cholinergic receptors. Skeletal muscle contraction is mediated through Nm receptors ...
Drug discovery
In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered. Historically, drugs were discovered through identifying the active ingredient from traditional remedies or by serendipitous discovery. Later chemical libraries of synthetic small molecules, natural products or extracts were screened in intact cells or whole organisms to identify substances that have a desirable therapeutic effect in a process known as classical pharmacology. Since sequencing of the human genome which allowed rapid cloning and synthesis of large quantities of purified proteins, it has become common practice to use high throughput screening of large compounds libraries against isolated biological targets which are hypothesized to be disease modifying in a process known as reverse pharmacology. Hits from these screens are then tested in cells and then in animals for efficacy.Modern drug discovery involves the identification of screening hits, medicinal chemistry and optimization of those hits to increase the affinity, selectivity (to reduce the potential of side effects), efficacy/potency, metabolic stability (to increase the half-life), and oral bioavailability. Once a compound that fulfills all of these requirements has been identified, it will begin the process of drug development prior to clinical trials. One or more of these steps may, but not necessarily, involve computer-aided drug design. Modern drug discovery is thus usually a capital-intensive process that involves large investments by pharmaceutical industry corporations as well as national governments (who provide grants and loan guarantees). Despite advances in technology and understanding of biological systems, drug discovery is still a lengthy, ""expensive, difficult, and inefficient process"" with low rate of new therapeutic discovery. In 2010, the research and development cost of each new molecular entity (NME) was approximately US$1.8 billion. Drug discovery is done by pharmaceutical companies, with research assistance from universities. The ""final product"" of drug discovery is a patent on the potential drug. The drug requires very expensive Phase I, II and III clinical trials, and most of them fail. Small companies have a critical role, often then selling the rights to larger companies that have the resources to run the clinical trials.Discovering drugs that may be a commercial success, or a public health success, involves a complex interaction between investors, industry, academia, patent laws, regulatory exclusivity, marketing and the need to balance secrecy with communication. Meanwhile, for disorders whose rarity means that no large commercial success or public health effect can be expected, the orphan drug funding process ensures that people who experience those disorders can have some hope of pharmacotherapeutic advances.